Medigen Vaccine Biologics Corporation (TPEX:6547)

Medigen Vaccine Biologics Revenue

In the year 2024, Medigen Vaccine Biologics had annual revenue of 605.64M TWD with 55.44% growth. Medigen Vaccine Biologics had revenue of 128.81M in the quarter ending December 31, 2024, a decrease of -24.82%.

• Revenue: 605.64M
• Revenue Growth: +55.44%
• P/S Ratio: 26.49
• Revenue / Employee: 5.88M
• Employees: 103
• Market Cap: 16.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	605.64M	216.01M	55.44%
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%
Dec 31, 2020	11.51M	10.39M	927.41%